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INTRODUCTION
Endovascular coiling is considered one of the standard 
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Objective: We aimed to evaluate the efficacy and safety of a newly developed, partially retrievable flow-diverter (the FloWise) 
in an elastase-induced rabbit aneurysm model.
Materials and Methods: We developed a partially retrievable flow diverter composed of 48 strands of Nitinol and platinum 
wire. The FloWise is compatible with any microcatheter of 0.027-inch inner diameter, and is retrievable up to 70% deployment. 
The efficacy and safety of the FloWise were evaluated in the elastase-induced rabbit aneurysm model. The rate of technical 
success (full coverage of aneurysm neck) and assessment of aneurysm occlusion and stent patency was conducted by angiograms 
and histologic examinations at the 1-month, 3-month, and 6-month follow-up. The patency of small arterial branches (intercostal 
or lumbar arteries) covered by the FloWise were also assessed in the 5 subjects.
Results: We attempted FloWise insertion in a total of 32 aneurysm models. FloWise placement was successful in 31 subjects 
(96.9%). Two stents (6.2%) were occluded at the 3-month follow-up, but there was no evidence of in-stent stenosis in other 
subjects. All stented aneurysms showed progressive occlusion: grade I (complete aneurysm occlusion) in 44.4% and grade 
II (aneurysm occlusion > 90%) in 55.6% at 1 month; grade I in 90% and II in 10% at 3 months; and grade I in 90% and II 
in 10% at 6 months. All small arterial branches covered by the FloWise remained patent.
Conclusion: A newly developed, partially retrievable flow-diverter seems to be a safe and effective tool of aneurysm occlusion, 
as evaluated in the rabbit aneurysm model.
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treatments for intracranial aneurysms. The most critical 
drawback of coiling is a higher aneurysm recurrence rate, 
as compared to clipping, particularly in wide-necked or 
large aneurysms. The flow-diverter stent was developed to 
overcome this drawback, and has produced superior results 
to conventional coiling for large aneurysms. However, the 
currently available flow-diverter stent is not retrievable 
once deployment is initiated, and shows foreshortening of 
> 50%. Thus, we developed a new flow-diverter stent that 
is both partially retrievable and shows less foreshortening. 
The purpose of this study was to evaluate the efficacy and 
safety of the newly developed flow-diverter (the FloWise, 
Angiovention, Seoul, Korea) in the elastase-induced rabbit 
aneurysm model. 
http://dx.doi.org/10.3348/kjr.2016.17.1.151
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MATERIALS AND METHODS
The study was approved by the Institutional Review 
Board for animal experiments. The FloWise is composed of 
36 strands of 0.0012-inch Nitinol wire and 12 strands of 
0.0012-inch platinum wire. These 48 strands are braided 
and heat-treated in the expanded configuration. After 
deployment from the delivery system, the FloWise expands 
to cover the neck of the aneurysm, forming a high-coverage 
mesh of approximately 33% up to 41% by area, with a 
radioopacity similar to that of the Pipeline embolization 
device (Covidien, Irvine, CA, USA) (Fig. 1A, B). The FloWise 
is attached to a flexible delivery wire, which has radiopaque 
end markers, and is packaged in an introducer sheath. 
The stent-contact portion of the delivery wire is coated 
with silicon so that it grips the FloWise, which allows for 
re-sheathing at any point prior to 70% deployment (Fig. 
1). This packaged device can be loaded into standard 
microcatheters with at least a 0.027-inch inner diameter. 
It is pushed through the microcatheter and deployed by 
a combination of microcatheter withdrawal and forward 
pressure on the delivery wire. The FloWise undergoes 
approximately 38% shortening when deployed completely. 
Table 1 showed the comparative properties of the FloWise 
with 2 other types of commercially available flow diverters 
(Pipeline, Covidien, Irvine, CA, USA; Silk, Balt Extrusion, 
Montmorency, France).
In Vivo Experiments
Elastase-induced aneurysms were created in 31 New 
Fig. 1. FloWise flow-diverter and its delivery system.
A. FloWise flow-diverter. B. Spot images of FloWise (left) with Pipeline (right). C. Delivery system of FloWise. Stent-contact portion of delivery 
wire is coated with silicon to hold stent, which makes it possible to re-sheath FloWise until < 70% deployed.
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Table 1. Properties of FloWise and Two Commercially Available Flow-Diverters
FloWise Pipeline Silk
Stent, diameter x length (mm) 4 x 20 4 x 20 4 x 20
In-sheath length (mm) 32 55 35
Deployed length (mm) 20 20 20
Foreshortening (%) 38 64 43
Metal coverage (%) 39 31 30
Pore size (mm2) 0.04 0.07 0.12
Radial force (gf) 3.5 3.4 1.9
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Zealand white rabbits, as previously reported (1, 2). 
Aneurysms were allowed to mature for at least 4 weeks 
before insertion of the FloWise. Five days prior to FloWise 
insertion, each rabbit received daily dual-antiplatelet 
therapy (aspirin 10 mg/kg and clopidogrel 10 mg/kg per 
os). Under general anesthesia, a surgical cut-down of the 
right femoral artery was performed, and a 5-Fr sheath 
was inserted. A 5-Fr Envoy guide catheter (Coddman 
Neurovascular, Miami Lakes, FL, USA) was placed into the 
aortic arch, and a digital subtraction angiogram (DSA) was 
obtained to confirm aneurysm creation, measure aneurysm 
neck and dome diameter, and measure the parent artery 
at points proximal and distal to the aneurysm. Heparin 
300 units was administered intravenously, and the guiding 
catheter was placed into the orifice of innominate artery. 
Next, a 0.027-inch microcatheter (Rebar, Covidien) was 
navigated over a 0.014-inch microguidewire into the right 
subclavian artery, distal to the aneurysm. The guidewire was 
removed, and the FloWise advanced and deployed across 
the aneurysm neck. Subsequently, the microcatheter was 
also removed, and DSA obtained at the aortic arch. In 5 
animals, an additional FloWise was placed in the thoracic 
and abdominal aorta, across the origin of at least 1 pair 
of intercostal or lumbar arteries. Following the removal of 
the guiding catheter and femoral sheath, the femoral artery 
was ligated. Antiplatelet therapy was continued for either 
30 days (1-month follow-up group) or 90 days (3-month 
and 6-month follow-up groups). The animals were followed 
for 1 month (n = 9), 3 months (n = 12), or 6 months (n = 
10). At follow-up, DSA was obtained at the aortic arch and 
descending aorta. The animals were then sacrificed with a 
lethal injection of pentobarbital. Harvested aneurysms and 
stented aortic segments were immediately fixed in 10% 
neutral buffered formalin.
Data Analysis
Follow-up angiograms assessed aneurysm occlusion using 
a 3-point scale: grade I for complete aneurysm occlusion; 
Table 2. Follow-up Angiographic Results after Insertion of FloWise
Follow-Up, Period Aneurysms, Number
Degree of Aneurysm Occlusion*
Grade I Grade II Grade III
1 month 9 4 (44.4%) 5 (55.6%) 0
2 months 10 9 (90%) 1 (10%) 0
6 months 10 9 (90%) 1 (10%) 0
Total 29 22 (75.9%) 7 (24.1%) 0
Data are numbers of aneurysms (percentage). *Grade I, complete occlusion; grade II, near occlusion (aneurysm occlusion greater than or 
equal to 90%); grade III, incomplete occlusion (less than 90%).
Fig. 2. Occlusion of FloWise.
A. Aortic angiogram shows tortuous and fusiform change of right subclavian artery close to elastase-induced aneurysm, possibly due to leakage 
of elastase into right subclavian artery. B. 4.5 x 20 mm FloWise stent was implanted from subclavian origin to right vertebral artery origin. 
Because subclavian artery appears tortuous and fusiform with 5.5 mm in fusiform segment, Flowise was deformed and enlarged with compaction 
of stent struts at fusiform segment (arrows). Angiogram just after Flowise implantation shows markedly decreased inflow into aneurysm sac due 
to more increased pore density and decreased porosity by stent strut compaction. C. However, at 3-month follow-up angiogram, Flowise is mildly 
shortened and occluded at fusiform segment of strut compaction and deformation. Arrowheads indicate proximal and distal ends of FloWise.
A B C
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grade II for > 90% occlusion of the aneurysm sac; and 
grade III for < 90% occlusion of the aneurysm sac, as 
previously reported (3, 4). Patency of the parent artery 
and its branches, including intercostal or lumbar arteries 
covered by the FloWise, was also assessed.
Histologic Processing and Analysis
After routine tissue processing, the fixed samples were 
embedded in paraffin. Samples were then sectioned at 5 
µm to 6 µm, and stained with hematoxylin and eosin. Axial 
sections were taken from the proximal, mid, and distal 
portions of the aneurysm’s parent artery. Morphometric 
measurements were performed using digital planimetry with 
a calibrated microscope system. Neointimal thickness was 
measured as the distance from the inner surface of each stent 
strut to the luminal border, as previously reported (3, 4).
For evaluation of the patency of stent-jailed branches, 
the stented segments of the aorta were harvested and 
prepared for the scanning electron microscope, as previously 
described (3, 4).
Statistical Analysis
Statistical analysis was performed using IBM SPSS version 
20 (IBM Corp., Armonk, NY, USA). Continuous variables 
Fig. 3. Representative angiograms showing grade I aneurysm occlusion, and photomicrograph from 1-month, 3-month, and 
6-month groups. 
A. Pre-stent angiogram showing saccular aneurysm. B. Angiogram just after FloWise insertion showing contrast medium filling only up to neck of 
aneurysm. C. One-month follow-up angiogram shows complete occlusion (grade I) of aneurysm sac. D. Photomicrograph (x 15) shows neointimal 
formation completely covering aneurysm.
A B
C D
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were presented as a mean ± standard deviation, and 
categorical variables as a number and percent. Comparisons 
of aneurysm size and parent artery neointimal thickness 
between the follow-up groups was performed using one-way 
analysis of variance. Statistical significance was determined 
at p < 0.05 for a 95% confidence interval. 
RESULTS
Aneurysm neck and sac sizes were 3.3 ± 1.1 mm and 6.5 
± 2.4 mm for the 1 month, 4.3 ± 1.4 mm and 7.2 ± 2.6 
mm for the 3 month, and 3.2 ± 1.2 mm and 6.9 ± 2.2 mm 
for the 6 month follow-up groups, respectively. There were 
no significant differences in neck or sac size among the 3 
groups with p value of 0.923 and 0.843, respectively.
The comparison among the FloWise and commercially 
available flow diverters were summarized in the Table 1 and 
the overall follow-up results were summarized in Table 2. 
Deployment of the FloWise was successful in 31 (96.9%) 
of 32 cases. In the only failed case, the distal end of the 
device had herniated into the aneurysm sac due to tortuous 
and fusiform change of the parent artery near the end of 
A
C
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Fig. 4. Representative angiograms and photomicrograph from 3-month group.
A. Pre-stent angiogram showing saccular aneurysm. B. Angiogram just after FloWise insertion shows contrast filling neck to less than third of 
aneurysm sac. C. 3-month follow-up angiogram shows complete occlusion (grade I) of aneurysm sac. D. Photomicrograph (x 15) shows neointimal 
formation completely covering aneurysm neck.
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the deployment. Of the 31 cases in which the FloWise was 
implanted bridging the aneurysm neck, 2 stents (6.2%) 
were occluded; in both cases, the parent artery showed a 
fusiform appearance with severe tortuosity (Fig. 2). The 
remaining 29 aneurysms were available for follow-up: 9 in 
the 1 month, 10 in the 3 month, and 10 in the 6 month 
groups. All stented aneurysms showed progressive occlusion: 
grade I (complete occlusion) in 4 aneurysms (44.4%) (Fig. 
3) and grade II (near occlusion) in 5 aneurysms (55.6%) at 
1 month; grade I in 9 (90%) (Fig. 4) and grade II in 1 (10%) 
at 3 months; and grade I in 9 (90%) (Fig. 5) and grade II 
in 1 (10%) at 6 months follow-up, respectively. There were 
no occurrences of in-stent stenosis.
The mean diameter of the lumbar artery origin was 1.2 
± 0.3 mm. No cases of lumbar artery occlusion were noted 
on follow-up angiography (Fig. 5A) or scanning electron 
microscopic examination (Fig. 6). The endothelial cells 
covering the stent were contiguous with the endothelium of 
the parent artery (Fig. 6).
In the 1-month group, histology revealed complete 
covering of the aneurysm neck by the neointima along 
stent struts in 4 of 9 aneurysms (Fig. 3), and partial 
Fig. 5. Representative angiograms and photomicrograph from 6-month group.
A. Pre-stent angiogram showing saccular aneurysm. B. Angiogram just after FloWise insertion shows contrast filling neck to < third of aneurysm 
sac. C. 6-month follow-up angiogram shows complete occlusion (grade I) of aneurysm sac. D. Photomicrograph (x 15) shows neointimal 
formation completely covering aneurysm neck.
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covering in the remaining 5 aneurysms, which showed 
grade II occlusion on follow-up angiogram. The 3-month 
group showed complete covering of the aneurysm neck 
by the neointima (Fig. 4) in 9 of 10 aneurysms, and 
partial covering in the remaining 1, which showed grade 
II occlusion on follow-up angiogram. The 6-month group 
showed complete covering of the aneurysm neck by the 
neointima (Fig. 5) in 9 of 10 aneurysms and partial covering 
in the remaining 1, which showed grade II occlusion on 
follow-up angiogram. Thus, histologic results were in exact 
concordance with those of follow-up angiograms. 
The neointimal thickness of the parent artery was a mean 
of 0.12 ± 0.09 mm for the one month, 0.11 ± 0.08 mm for 
the 3 month, and 0.15 ± 0.12 mm for the 6 month groups, 
respectively. There were no significant differences in 
neointimal thickness among the follow-up groups. 
DISCUSSION
This study presents the efficacy and safety data of a 
newly developed flow-diverter stent, the FloWise, in the 
elastase-induced rabbit aneurysm model. The FloWise was 
highly trackable, with a radioopacity similar to that of the 
Pipeline. It had radial force and metal coverage capacities 
greater than that of the Pipeline or the Silk, while showing 
less foreshortening than both devices. In-vivo, the FloWise 
demonstrated a 100% complete or near occlusion rate. In 
addition, it was possible to re-sheath the FloWise up till 
70% deployment, allowing for greater flexibility with device 
re-positioning. 
As in previous reports, all small lumbar arteries covered 
by the FloWise remained patent, likely due to runoff 
blood flow. However, as perforator artery occlusion has 
been reported after Pipeline implantation in humans, the 
patency of perforator arteries with the FloWise is not always 
guaranteed in humans. 
In this in-vivo experiment, there were 2 cases of stent 
occlusion on follow-up angiography. Both cases occurred 
in markedly tortuous, fusiform-appearing parent arteries, 
which was likely due to leakage of elastase into the parent 
artery during aneurysm creation. This appearance made it 
difficult to cross the aneurysm neck with the microcatheter, 
resulting in twisting, compaction of struts with increased 
stent diameter, and incomplete apposition of the FloWise to 
the parent artery wall; this in turn might have caused in-
stent thrombosis and eventual stent occlusion (Fig. 6). 
Several types of flow-diverters are used for intracranial 
aneurysm occlusion in clinical practice, particularly for 
treatment of large and giant aneurysms (5-8). According 
to recent meta-analysis, the complete occlusion rate was 
76% overall, with 80% for small, 74% for large, and 76% 
for giant aneurysms. The procedure-related morbidity and 
mortality rates were 5% and 4%, respectively. The rate of 
postoperative subarachnoid hemorrhage was 3%, and rate 
of intraparenchymal hemorrhage was 3%. The perforator 
infarction rate was 3%, with significantly lower rates of 
A B C
Fig. 6. Representative angiogram and scanning electron microscopies after FloWise insertion into descending aorta.
A. 6 month follow-up angiogram shows patent intercostal and lumbar arteries. B. Electron microscopy (x 20) shows patent lumen of lumbar artery 
covered by struts of FloWise. C. Electron microscope (x 50) shows that tissue covering struts at orifice of lumbar artery is contiguous with that of 
device at aorta.
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perforator infarction in patients with anterior circulation 
versus posterior circulation (9). Although the risk of 
procedure-related morbidity and mortality is not negligible, 
the treatment of intracranial aneurysms with flow-diverters 
is feasible and effective, yielding high complete occlusion 
rates when used for large, giant, uncoilable, or failed 
aneurysms (5, 9, 10).
Until now, the Pipeline, the only flow-diverter that is 
available in Korea, has several drawbacks. First, because 
of its high cost, reimbursement is given only to aneurysms 
≥ 15 mm in diameter. Second, it is mainly composed of 
a Co-Cr alloy, so that the self-expanding radial force is 
often insufficient for proper positioning of the device to 
the vessel wall, especially in a tortuous parent artery. As 
described, the FloWise demonstrates increased radial force, 
better metal coverage, and less foreshortening than both 
the Pipeline and the Silk (Table 1). Additionally, it allows 
for re-sheathing, making repositioning possible until 70% 
stent deployment. Thus, FloWise may be easier to use than 
currently available flow-diverters. 
This study had several limitations. We did not directly 
compare the FloWise and other commercially available 
flow-diverters. However, because we performed in-vivo 
experiments under the same conditions as in previous in-
vivo reports (3, 4), it is reasonable to conclude that the 
FloWise would function similarly to commercially available 
flow diverters in clinical practice. 
In conclusion, a newly developed, partially retrievable 
flow-diverter, the FloWise, might provide a safe and 
effective method of aneurysm occlusion, as evaluated in an 
elastase-induced rabbit aneurysm model. 
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